Embecta (EMBC) is a medical devices company focused on diabetes management. It offers a variety of pen needles, syringes, and other assorted tools to help diabetic patients. A much larger company, ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Embecta Corp. (NASDAQ:EMBC) posted on Friday the second-quarter 2025 adjusted earnings of 70 cents per share, up from 67 cents a year ago, beating the consensus of 53 cents. The diabetes care company ...
Shares of Embecta (EMBC) have been trading at multi-year lows as investors fear the overhang of GLP-1 success, with Embecta posting flattish sales at best, yet being able to post strong margins. That ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results